IHS Chemical Week

World News and Views :: Top of the News

Sanofi-Aventis to Acquire Genzyme for $20.1 Billion

11:59 PM MST | February 15, 2011 | Deepti Ramesh

Sanofi-Aventis says it has entered into a definitive agreement with biotechnology company Genzyme (Cambridge, MA), under which Sanofi-Aventis will acquire Genzyme for $74/share in cash, or about $20.1 billion. The transaction, which has been approved by the boards of directors of both companies, is expected to close early in the second quarter of 2011. The combination will enhance Sanofi-Aventis’ growth strategy by expanding its footprint in biotechnology, Sanofi-Aventis says. Genzyme, since 1981, has grown from a small start-up to a diversified enterprise...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa